All studies
Active not recruitingNAINTERVENTIONAL

JIA Toolbox Feasibility Study

This study is investigating new tools, called the 'JIA Toolbox', designed to help children and young people in the UK who have Juvenile Idiopathic Arthritis (JIA). JIA is a long-term condition causing joint pain and stiffness, making daily activities difficult. These tools were created with young people and aim to improve their independence, help manage pain, encourage exercise, and make communication easier at school. This new study will involve 25 children aged 7-16 using the tools for three months to see how well they work and help them in everyday life. We hope these tools will help young people with JIA feel more in control and live fuller lives.

At a glance

Status
Active not recruiting
Phase
NA
Sponsor
Sheffield Children's NHS Foundation Trust
Enrolment target
25
Start
21 May 2024
Estimated completion
31 May 2026

What is this study about?

Juvenile Idiopathic Arthritis (JIA) is a type of arthritis that affects children and young people. It can cause ongoing joint pain and stiffness, making simple things like playing or going to school a real challenge. We know that JIA doesn't just affect the body; it can also impact social life, emotions, and how well a child does at school. Previous studies have shown that many current aids for JIA can be difficult to use and might make young people feel singled out.

That's why we've developed the 'JIA Toolbox'. This project grew out of earlier work where we asked young people with JIA, their parents, and doctors what they needed. They helped us create three special tools: one for managing pain, one to help with exercises recommended by physiotherapists, and a third to make it easier for young people to communicate with their teachers when they need help in a discreet way. The idea is for these tools to help young people manage their condition themselves, feel more independent, and improve their ability to do everyday activities.

We've already done an initial test with 10 young people, and the results were very positive. Now, we're inviting 25 children and young people, aged 7 to 16, to try out these tools for three months. We want to understand how suitable and useful these tools are in real-life situations. Participants will share their experiences with JIA and how the tools help them. By doing this, we hope to gather more evidence that these tools can truly make a difference in the lives of young people with JIA, helping them to be more active and independent.

Key takeaways

  • New tools (JIA Toolbox) are being tested to help young people with JIA.
  • The tools aim to improve independence, pain management, exercise, and school communication.
  • The study involves using the tools for three months and sharing your experiences.
  • It's for young people aged 7-16 with JIA.
  • Your feedback will help shape future support for JIA.

Who may be eligible?

To take part in this study, children and young people need to be between 7 and 16 years old. They must have a diagnosis of Juvenile Idiopathic Arthritis (JIA) and be able to speak and write in English fluently. They'll also need access to a computer with internet so they can join online workshops related to the study.

Children and young people won't be able to join if they are younger than 7 or older than 16. Also, those who are not fluent in English, have an autism spectrum disorder, experience pain that doctors cannot explain, or have other joint or muscle problems apart from JIA will not be able to participate. This is to make sure the study focuses on how the tools help specifically with JIA.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you between 7 and 16 years old?
  2. Do you have a diagnosis of Juvenile Idiopathic Arthritis (JIA)?
  3. Can you speak and write fluently in English?
  4. Do you have access to a computer with internet?
  5. Do you not have an autism spectrum disorder or other non-JIA joint/muscle pain?
Answer every question to see your result.

What does participation involve?

If you decide to take part, the study will involve several steps over a few months. Initially, for two weeks, we'll ask you to share information about your daily experiences with JIA through self-reporting. After this, you will use the 'JIA Toolbox' prototypes for three months. During this time, you'll continue to report on your condition management, and the prototypes themselves will quietly collect information on how they are being used. Following the three months of using the tools, we'll collect more data from you for another two weeks. Finally, we'll invite you to an interview to discuss your experience with the study and the tools. There are no medications involved in this study.

Potential risks and benefits

Participating in this study offers the potential benefit of trying new tools designed to help you manage your JIA and potentially improve your independence and daily activities. Your feedback will also be crucial in shaping future innovations for young people with JIA. We don't expect any serious risks, but some participants might find the data collection or interviews a little time-consuming. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Sheffield Children's NHS Foundation Trust
    Verified postcode
    Sheffield, United Kingdom

Common questions

What is Juvenile Idiopathic Arthritis (JIA)?

JIA is a type of arthritis that affects children and young people, causing joint pain, swelling, and stiffness.

What are the 'JIA Toolbox' prototypes?

These are three new tools being tested that aim to help young people with JIA manage pain, do their physiotherapy exercises, and communicate better at school.

How long will I have to use the tools?

Participants will use the 'JIA Toolbox' prototypes for three months, as part of a longer study period of around 4.5 months in total.

Will I have to take any new medicines?

No, this study does not involve any new medications.

Where is this study taking place?

We are recruiting participants from Sheffield Children's Hospital in the UK.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.